Newsmeme!
Discover News you didn't know existed
Upregulation
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Cell Cycle Kinases as Therapeutic Targets for Cancer
Published July 3, 2009, 3:34 am, Newswise
A featured article in the July 2009 online issue of Nature Reviews/Drug Discovery that explores the prospects and progress of synthetic inhibitors to target cell cycle kinases in cancer forecasts that "novel compounds with increased potency, improved kinase specificity and favorable drug like properties will soon be available for clinical evaluation."
Stemedica Discovers Significant Breakthrough In The Use Of Stem Cells And Stem Cell Factors For The Treatment Of ...
Published July 3, 2009, 3:31 am, BioresearchOnline
Stemedica Cell Technologies, Inc., ("Stemedica"),a leader in the manufacturing and development of clinical grade allogeneic adult stem cell technology, has discovered a significant breakthrough in the use of human stem cells and stem cell factors for the potential treatment of degenerations of the retina and retinal pigmented epithelium.
Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of ...
Published July 1, 2009, 12:12 am, PRWeb
Stemedica Cell Technologies, Inc., a leader in the manufacturing and development of clinical grade allogeneic adult stem cell technology, has discovered a significant breakthrough in the use of human stem cells and stem cell factors for the potential treatment of degenerations of the retina and retinal pigmented epithelium. (PRWeb Jul 1, 2009) Read the full story at ...
Human Gastric Cancer: A Potent And Selective Anti-Tumor Agent
Published June 30, 2009, 4:08 am, Medical News Today
A research article published in the World Journal of Gastroenterology refers. The research team led by Professor Yan Li from Shengjing Hospital of China Medical University studied the growth inhibitory effects of Alisol B acetat and determined its mechanism of antitumor activity in human gastric cancer cell line SGC7901.
A Potent And Selective Anti-tumor Agent On Human Gastric Cancer
Published June 29, 2009, 10:00 am, redOrbit
A research article to be published on June 21, 2009 in the World Journal of Gastroenterology addresses this question.
A potent and selective anti-tumor agent on human gastric cancer
Published June 29, 2009, 7:48 am, PhysOrg
A research article to be published on June 21, 2009 in the World Journal of Gastroenterology addresses this question. The research team led by Professor Yan Li from Shengjing Hospital of China Medical University studied the growth inhibitory effects of Alisol B acetat and determined its mechanism of antitumor activity in human gastric cancer cell line SGC7901.
A potent and selective anti-tumor agent on human gastric cancer
Published June 29, 2009, 6:08 am, EurekAlert!
Alisol B acetat has been traditionally used in treatment of urological, and allergic reactionl diseases in China. Studies indicate that Alisol B acetate, a triterpene from Alismatis rhizome, has growth inhibitory effects on a number of human cancers. Reports are available on the treatment of hepatoma, leukemia, and prostate cells. However, no detailed data are available about the role and ...
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |